NASDAQ
KalVista Pharmaceuticals, Inc. (KALV) has a fcf yield of -10.14% as of Friday, May 29, 2026. This represents a 59.53% increase compared to its 12-month average of -25.05%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.